|
01 Dec 2025 |
HCL Technologies
|
Consensus Share Price Target
|
1642.90 |
1648.93 |
- |
0.37 |
buy
|
|
|
|
|
15 Oct 2024
|
HCL Technologies
|
Motilal Oswal
|
1642.90
|
2300.00
|
1870.10
(-12.15%)
|
|
Buy
|
|
|
HCL Technologies (HCLT) reported a muscular 2QFY25, with revenue of USD3.4b, up 1.6% QoQ (~2.5% organic)
|
|
15 Oct 2024
|
HCL Technologies
|
ICICI Direct
|
1642.90
|
1840.00
|
1870.10
(-12.15%)
|
Target met |
Hold
|
|
|
|
|
15 Oct 2024
|
HCL Technologies
|
Prabhudas Lilladhar
|
1642.90
|
2130.00
|
1870.10
(-12.15%)
|
|
Buy
|
|
|
|
|
15 Oct 2024
|
HCL Technologies
|
BOB Capital Markets Ltd.
|
1642.90
|
|
1870.10
(-12.15%)
|
|
Not Rated
|
|
|
Broad-based and better-than-expected growth. Guidance is broadly left unchanged. HCLT does not want to extrapolate strong 2Q into 2H
|
|
15 Oct 2024
|
HCL Technologies
|
IDBI Capital
|
1642.90
|
1856.00
|
1870.10
(-12.15%)
|
Target met |
Hold
|
|
|
|
|
15 Oct 2024
|
HCL Technologies
|
ICICI Securities Limited
|
1642.90
|
1710.00
|
1855.90
(-11.48%)
|
Target met |
Sell
|
|
|
HCLT has reported a beat vs our and consensus estimates on both revenue and margin fronts in Q2FY25. Discretionary spends picked up in BFSI and technology services.
|
|
14 Oct 2024
|
HCL Technologies
|
Sharekhan
|
1642.90
|
2120.00
|
1855.90
(-11.48%)
|
|
Buy
|
|
|
? HCL Tech reported revenue of $3,445 million, up 1.6% q-o-q/6.2 % y-o-y in CC terms, beating our estimates of 0.6% q-o-q growth in CC.
|
|
29 Aug 2024
|
HCL Technologies
|
BOB Capital Markets Ltd.
|
1642.90
|
|
1751.85
(-6.22%)
|
|
Not Rated
|
|
|
Did not change its near-term commentary while being bullish on the medium-term outlook
|
|
29 Aug 2024
|
HCL Technologies
|
Sharekhan
|
1642.90
|
2000.00
|
1751.85
(-6.22%)
|
Target met |
Buy
|
|
|
We maintain Buy rating with revised price target (PT) of Rs 2,000 (valued at 27x Sep2026E EPS). At CMP, the stock trades at 27.3/25/22.7x its FY25/26/27E EPS.
|
|
29 Aug 2024
|
HCL Technologies
|
Motilal Oswal
|
1642.90
|
2000.00
|
1751.85
(-6.22%)
|
Target met |
Buy
|
|
|
We attended HCLT’s Investor Day 2024 wherein the management outlined its strategic objectives and showcased its capabilities in GenAI. We believe HCLT’s go-to-market (GTM) strategy, which combines its IT Services and ER&D business offerings.
|